Slide 1: Q2 2024 Results Call
Q2 2024 RESULTS CALL
Slide 2: Disclaimer
iY Cellebrite DISCLAIMER This presentation has been prepared by Cellebrite DI Ltd. [the “Company’! solely for informational purposes. It is not, and should not be assumed to be, complete. This presentation is not an offer to sell securities, nor is ita solicitation of an offer to buy securities, Thi
Slide 3: Q2 2024 Agenda: Results Highlights, Accomplishments, Priorities, Outlook
i Cellebrite 02.2024 RESULTS ACCOMPLISHMENTS STRATEGIC PRIORITIES & OUTLOOK & FINANCIAL REVIEW HIGHLIGHTS & PROGRESS CUSTOMER SUCCESS SUMMARY August 15, 2024 3
Slide 4: Q2 2024 Results Highlights
2 Cellebrite August 15, 2024 Q2 2024 > $96M +25% Total Revenue - Q2 24 > $85M 427% Subscription Revenue - Q2 24 » $346M +26% ARR - JUNE 24 > $22M 23% Adj. EBITDA & Adj. EBITDA %* - Q2 24 *Non-GAAP Note: non-GAAP metrics and key performance indicators defined in the appendix along with a reconcil RES
Slide 5: Key Strategic Accomplishments & Progress
** Getebrte a KEY STRATEGIC ACCOMPLISHMENTS & PROGRESS Cellebrite FEDERAL»SOLUTIONS August 15, 2024 5
Slide 6: Q2 2024 Strategic Priorities & Customer Success
2 Cellebrite a2 2024 STRATEGIC PRIORITIES & CUSTOMER SUCCESS GROWTH WITHIN LEADERSHIP IN DIGITAL EXPAND STRATEGICALLY IN INVESTIGATIVE & LEADING WITH CLOUD August 15, 2024 6
Slide 7: Q2 2024 Outlook & Summary
2 Cellebrite a2 2024 OUTLOOK & SUMMARY + We view our C2C platform as unique in today’s marketplace, enabling us to deliver an end-to-end set of integrated software solutions that supports our customers’ needs throughout the digital investigation lifecycle + As we look ahead, our updated 2024 expecta
Slide 8: i Cellebrite 2024
i Cellebrite 02 2024 ) cy | a
Slide 9: ARR Growth
2° Cellebrite 2 2024 AR R G ROWT H ($ in millions) + @Q224 ARR grew 26% $345.9 + Gross retention ~91% $273.7 + Existing customer expansion fuels most of the ARR growth + New logos contribute ~2% percentage points to ARR expansion Jun-24 Jun-24 mJun-23ARR mlnseyets Pathfinder & Guardian August 15, 20
Slide 10: Revenue Growth Driven by Subscription
“cuewte = REVENUE GROWTH DRIVEN BY SUBSCRIPTION $95.7 25% Total revenue growth 27% Total subscription revenue growth a223 a3 23 a4 23 Qi 24 a2 24 0225 0224 Hi otal subscription Wlother non-recurring* Hl Professional services Note: Numbers may not total 100% due to rounding. Note: Numbers may not tot
Slide 11: 14.4 15.3 70.0 12.0 12.6 12.4 12.8 60.9 53.6 54.7 57.6 52.5
14.4 15.3 70.0 12.0 12.6 12.4 12.8 60.9 53.6 54.7 57.6 52.5
Slide 12: Adjusted EBITDA & Cash Position
Ceieorte mame ADJUSTED EBITDA & CASH POSITION Adjusted EBITDA (Non-GAAP, $M) and Cash Position Adjusted EBITDA Margin (Non-GAAP, %} $366.0M (6/30/24) +$18.7M from Q1 24 | +$121.4 from Q2 23 24% 23% 25% $22.7 $20.8 20% $17.6 Cash and cash equivalents 29% 15% 10% Short-term and long-t. a marketable se
Slide 13: Financial Forecast
2° Cellebrite 02 2024 ARR ARR Growth [y/y) Revenue Revenue Growth (y/y] Adjusted EBITDA* Adjusted EBITDA Margin* * Non-GAAP 2023A $316M +27% $325M +20% $61.9M 19.1% FINANCIAL FORECAST Q3 ‘24 EXPECTATIONS FY ‘24 EXPECTATIONS (AS OF 8/15/24) (AS OF 8/15/24) $366M - $374M $388M - $400M #24% - +27% +23%
Slide 14: i Cellebrite 2024
i Cellebrite 02 2024 ? ° P gilt : o\4 Bape gigddl tiie ith . ee igo peiiae ° : * oo ee ° 2 a8”, fe e fig dtaty; ise: : VARS SRS e e - Wt ee . e Ce oe ‘ e 32 +3 % a 5S ae a oy, * of lh» ‘ at ig ‘a . . ‘ acs fee SRSA oe, pbeteersee setts ev ~~ 6 . +s >> i. i.e ef . “\\ - * fo _* . » &
Slide 15: i Cellebrite 2024
i Cellebrite 02 2024 ? ° P gilt : o\4 Bape gigddl tiie ith . ee igo peiiae ° : * oo ee ° 2 a8”, fe e fig dtaty; ise: : VARS SRS e e - Wt ee . e Ce oe ‘ e 32 +3 % a 5S ae a oy, * of lh» ‘ at ig ‘a . . ‘ acs fee SRSA oe, pbeteersee setts ev ~~ 6 . +s >> i. i.e ef . “\\ - * fo _* . » &
Slide 16: Summary Financial Data, Three and Six Months Ended June 30
For the three months ended For the six months ended June 30, June 30, 2024 2023 2024 2023 (Unaudited) (Unaudited) (Unaudited) (Unaudited) Revenue 95,714 76,684 185,296 147,918 Gross profit 79,453 63,653 155,771 122,481 Gross margin 83.0% 83.0% 84.1% 82.8% Operating income 12,487 4,623 21,734 4,759 O
Slide 17: Non-GAAP Cost of Revenues and Gross Profit Reconciliation
For the three months ended For the six months ended June 30, June 30, 2024 2023 2024 2023 (Unaudited) (Unaudited) (Unaudited) (Unaudited) Cost of revenues $ 16,261 $ 13,031 $ 29,525 $ 25,437 Less: Share based compensation 663 414 1,093 800 Acquisition related costs — 14 2 27 Non-GAAP cost of revenue
Slide 18: Non-GAAP Operating Expenses and Operating Income Reconciliation
For the three months ended For the six months ended June 30, June 30, 2024 2023 2024 2023 (Unaudited) (Unaudited) (Unaudited) (Unaudited) Operating expenses $ 66,966 $ 59,030 $ 134,037 $ 117,722 Less: Issuance expenses — (345) — (345) Share based compensation 5,892 4,186 11,158 8,257 Amortization of
Slide 19: Non-GAAP Net Income Reconciliation
For the three months ended For the six months ended June 30, June 30, 2024 2023 2024 2023 (Unaudited) (Unaudited) (Unaudited) (Unaudited) Net loss $ (23,811) $ (32,348) $ (95,183) $ (72,953) Issuance expenses — (345) — (345) Share based compensation 6,555 4,600 12,251 9,057 Amortization of intangibl
Slide 20: Adjusted EBITDA Reconciliation
For the three months ended For the six months ended June 30, June 30, 2024 2023 2024 2023 (Unaudited) (Unaudited) (Unaudited) (Unaudited) Net loss $ (23,811) $ (32,348) $ (95,183) $ (72,953) Financial expense, net 34,502 36,051 113,078 74,826 Tax expense 1,796 920 3,839 2,886 Issuance expenses — (34
Slide 21: Appendix: Definitions
2 Cellebrite APPENDIX DEFINITIONS 1. Annual Recurring Revenue: Annual recurring revenue (ARR) is defined as the annualized value of active term-based subscription license contracts and maintenance contracts related to perpetual licenses in effect at the end of that period. Subscription license contr
Slide 22: Thank You
Cellebrite Q2 2024 THANK YOU August 15, 2024